Details for 2018169211
Up to date per 02.04.2026
Actions
Details for 2018169211
Granted/Registered
European Patent
12.09.2018 A
24.03.2021 B1
06.06.2014
US
201462008939 P
A61K 31/437 20060101AFI20180606BHEP
Owner
Ovid Therapeutics, Inc.1460 Broadway New York, NY 10036US
Representative
No representatives present
Inventor
During, Matthew14 Cedar Lane Weston CT Connecticut 06883US
Information about Fees